It was only a matter of time — scientists have reportedly found a subvariant of the omicron variant, raising questions about what’s going to happen next with the novel coronavirus.

The news: Scientists across the world have found a sublineage of the highly-transmissible omicron coronavirus variant, called BA.2.

  • The BA.2 variant is now under investigation because it could have a growth advantage, replacing the original omicron variant, per Reuters.

Why this matters: The subvariant BA.2, which has been nicknamed the “stealth omicron,” could be spreading faster than the original omicron and lead to even more COVID-19 cases, according to Fortune.

Details: Dr. Eric Feigl-Ding, an epidemiologist and health economist and a senior fellow at the Federation of American Scientists, said he is “concerned” about the new subtype because it is surging.

  • Cases of omicron subvariant are doubling about every four days, he tweeted. The delta variant cases doubled every 1.5 to three days.
  • That said, omicron cases doubled quicker than every four days. But “BA2 displacing Omicron BA1 is a really bad sign,” Feigl-Ding said.
Related
Why the omicron variant might not signal the end of COVID-19
Could omicron end the COVID-19 pandemic? It’s too early to tell

Around the world: Denmark’s number of subvariant cases recently surpassed the original omicron variant, Feigl-Ding said.

  • The United Kingdom is on pace to see the same situation.
  • Germany is seeing a rise on the B.A.2 subvariant as well, but it is still early to see how much it will impact numbers,

Yes, but: “Initial analysis shows no differences in hospitalizations for BA.2 compared to BA.1,” said Denmark’s Statens Serum Institut, a government-funded infectious disease research center, in a statement. “It is expected that vaccines also have an effect against severe illness upon BA.2 infection.”

One last note: The BA.2 variant could be considered its own variant since it has a number of mutations, much like the omicron variant, according to Shay Fleishon, a researcher affiliated with the Israeli government’s Central Virology Laboratory.

  • “I think the responsible thing to do is to relate to BA.2 as a completely different variant, outcompeting BA.1,” Fleishon wrote on Twitter. “Oh and if someone in the WHO is here — The letter Pi is still waiting. Just saying.”
Join the Conversation
Looking for comments?
Find comments in their new home! Click the buttons at the top or within the article to view them — or use the button below for quick access.